L-Carnitine

Description

• Pack

20 capsules

• Composition

Each hard gelatin capsule contains:

L-Carnitine tartarate                   512.45 mg

Equivalent to L-carnitine base   350 mg 

• Indication

• L-Carnitine is indicated in the treatment of primary systemic carnitinedeficiency.

• In the reported cases, the clinical presentation consisted of recurrent episodes of Reye-like encephalopathy, hypoketotic hypoglycemia, and/or cardiomyopathy.

• Associated symptoms included hypotonia, muscle weakness and failure to thrive.

• A diagnosis of primary carnitine deficiency requires that serum, red cell and/or tissue carnitine levels be low and that the patient does not have a primary defect in fatty acid or organic acid oxidation.

• In some patients, particularly those presenting with cardiomyopathy, carnitine supplementation rapidly alleviated signs and symptoms.

• Treatment should include, in addition to carnitine, supportive and other therapy as indicated by the condition of the patient.

• L-Carnitine is also indicated for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency.